203 related articles for article (PubMed ID: 8876934)
1. Effects of the new calcium antagonist efonidipine hydrochloride on resting and exercise hemodynamics in patients with stable effort angina.
Saito T; Fujii K; Takizawa T; Toyosaki T; Kuwabara Y; Kobayashi S; Ichikawa H; Karaki A; Yamazaki Y; Iwata J; Yamada K; Tomiya H; Takeda K; Inagaki Y
Arzneimittelforschung; 1996 Sep; 46(9):861-7. PubMed ID: 8876934
[TBL] [Abstract][Full Text] [Related]
2. [Effects of efonidipine hydrochloride, a calcium antagonist derived from dihydropyridine, on acute myocardial ischemia in anesthetized open-chest dogs].
Yokoyama T; Fujikura N; Masuda Y; Shikada K; Tanaka S
Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):307-21. PubMed ID: 9017685
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities.
Harada K; Nomura M; Nishikado A; Uehara K; Nakaya Y; Ito S
Circ J; 2003 Feb; 67(2):139-45. PubMed ID: 12547996
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of the calcium channel blocker pranidipine on exercise-induced angina.
Nishinaka Y; Yokota M; Watanabe M; Sobue T; Iwase M; Ukai M; Ando A; Nagata K; Saito H
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):542-9. PubMed ID: 7834162
[TBL] [Abstract][Full Text] [Related]
5. [Effect of efonidipine hydrochloride (NZ-105), a new dihydropyridine calcium antagonist, on the experimental atherosclerosis in cholesterol-fed rabbits].
Toyoda K; Kitahara M; Yamashita T; Shudo C; Masuda Y; Sakashita M; Tanaka S; Saito Y
Nihon Yakurigaku Zasshi; 1994 May; 103(5):231-9. PubMed ID: 8188119
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
Sakoda R; Kamikawaji Y; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
[TBL] [Abstract][Full Text] [Related]
7. Effect of nipradilol on cardiovascular hemodynamics during exercise in angina pectoris with old myocardial infarction.
Saito T; Sekiya T; Yamazaki Y; Makita K; Udaka Y; Inagaki Y
Arzneimittelforschung; 1992 Oct; 42(10):1195-9. PubMed ID: 1361735
[TBL] [Abstract][Full Text] [Related]
8. Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
Suzuki S; Hashimoto T; Kusano S; Kapuku K; Utsunomiya T; Yano K
Arzneimittelforschung; 1993 Nov; 43(11):1152-6. PubMed ID: 8292057
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
Kuhn A; Carlsson J; Miketic S; Tebbe U
Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic and radionuclide effects of amlodipine in coronary artery disease.
Silke B; Verma SP; Zezulka AV; Sharma S; Reynolds G; Jackson NC; Guy S; Taylor SH
Br J Clin Pharmacol; 1990 Apr; 29(4):437-45. PubMed ID: 2139339
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term oral administration of NZ-105, a novel calcium antagonist, with or without propranolol in spontaneously hypertensive rats.
Shudo C; Masuda Y; Sakai T; Tanaka S; Shigenobu K; Kasuya Y
J Pharm Pharmacol; 1993 Jun; 45(6):525-9. PubMed ID: 8103100
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
Sakoda R; Matsumoto H; Seto K
Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral isradipine on left ventricular function at rest and during exercise in patients with stable chronic angina: a double-blind, placebo-controlled crossover study.
Delonca J; Kipfer P; Righetti A
J Cardiovasc Pharmacol; 1992 Jan; 19(1):126-33. PubMed ID: 1375679
[TBL] [Abstract][Full Text] [Related]
15. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
[TBL] [Abstract][Full Text] [Related]
16. [Effect of efonidipine hydrochloride (NZ-105) on modification of low density lipoprotein induced by rat cultured endothelial cells].
Ito S; Higashino R; Tanaka T; Takei M; Kurimoto T; Matsuda K
Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):263-70. PubMed ID: 8537073
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
18. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
[TBL] [Abstract][Full Text] [Related]
19. Immediate and longer-term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.
Visser CA; Jaarsma W; Kan G; Lie KI
Postgrad Med J; 1984; 60 Suppl 4():17-20. PubMed ID: 6527974
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line.
Tamura T; Saigusa A; Kokubun S
Naunyn Schmiedebergs Arch Pharmacol; 1991 Apr; 343(4):405-10. PubMed ID: 1649411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
